Bringing you the latest information from health industry experts.
The Future of Healthcare: LifeQ, the provider of biometrics and health information derived from wearable devices
Laurie Olivier, the Chief Executive Officer of LifeQ, the leading independent provider of biometrics and health information derived from wearable devices used in world leading health management solutions joins eHealth Radio and the Healthcare and Technology Channels.
Listen to interview with host Eric Michaels and guest Laurie Olivier discuss the following:
You bring over three decades of global technology and business leadership as CEO and founder of LifeQ, and you have served on the boards of more than 50 startup, private and public companies around the world. Tell us about yourself, and how you founded LifeQ.
What is LifeQ’s mission, and what does it do that is currently not being done?
Tell us about the biggest pain points when it comes to the digital aspect of healthcare, as well as your outlook on health and wellness technology.
How is LifeQ sequencing its coverages of the cardiovascular, respiratory, sleep, fitness, mental, musculoskeletal, renal and other areas?
How do you foresee LifeQ fitting into the future of healthcare and the overall health and wellness of people who use it?
Laurie Olivier is the Chief Executive Officer of LifeQ, the leading independent provider of biometrics and health information derived from wearable devices used in world leading health management solutions. Mr. Olivier leads the firm’s growth and overall vision, including investment, strategy and partnerships with global leaders in wearables, silicon manufacturers, digital platforms, and insurance companies — leading the movement toward improving health and wellness around the world.
Mr. Olivier brings over three decades of global technology and business leadership, thirty years of venture capital and private equity experience, and has served on the boards of more than 50 startup, private and public companies around the world, including the largest industrial conglomerate in South Africa. As the Atlanta-based partner of 4Di Capital, the South African based early-stage venture capital management firm, and the US-based partner of Veritas Venture Partners, a pioneering seed stage Israeli VC firm, Mr. Olivier is passionate about developing new technologies into startups that positively impact people and society.
Founded in 2014, LifeQ has two key value propositions: enable wearable devices to provide business and near clinical-grade health information streams; and generate health and wellness solutions for consumer, business and clinical applications.
Mr. Olivier earned his Bachelor of Science in Electronics Engineering from the University of Pretoria; a Bachelor of Commerce in Finance and Strategic Marketing; and a Diploma in Datametrics and Operational Research from the University of South Africa. Mr. Olivier’s work has been recognized by Dow Jones Venture Reporter, the Atlanta Journal Constitution, and the American Israel Chamber of Commerce. A native of Groot Marico, South Africa, Mr. Olivier lives in Atlanta with his wife.
Social Media Links:
Growth of Medical Travel and Fostering Healthcare Innovation in the Not-for-Profit Healthcare Sector
Alisha Moopen, Deputy Managing Director of Aster DM Healthcare, one of the largest private healthcare service providers operating in multiple GCC states and India with 27 hospitals, 115 clinics and 223+ pharmacies in seven countries joins eHealth and the Healthcare and Health News Channels.
Listen to interview with host Eric Michaels and guest Alisha Moopen discuss the following:
What is your background?
How did you get involved with the Thought Leadership & Innovation Foundation (known as the TLI Foundation) as an executive with Aster DM Healthcare?
What will be role as a board member for the TLI Foundation in connection with your Aster work?
Could you provide our listeners with information about ASTER DM Healthcare and its worldwide reach?
What are your expansion plans in the Western Hemisphere – the Cayman Islands project? Give our listeners the timeline for launch and overview of services.
How will your services expand the options for more affordable, quality care?
Can you give some examples of ways that ASTER DM has helped undeserved populations – particularly children in need?
Are your services available to worldwide audiences and how many people typically take advantage of medical value travel to ASTER DM hospitals?
Alisha Moopen is the Deputy Managing Director of Aster DM Healthcare. Having joined the company as a Director in 2013, she is responsible for overseeing the strategic direction and development of the company, and notably spearheading the expansion of the group into new markets.
Alisha was recently elected by World Economic Forum as a Young Global Leader to join the class of 2018. Recognizing her past work in healthcare, she has been inducted into a 5-year program with like-minded people who are committed and passionate to tackle the main challenges of the world today, with healthcare being one of them. She was also recognized as one of the Top 100 World’s Greatest Leaders in Asia and GCC in 2018. Forbes Middle East magazine has selected Alisha as one of the Top Next Generation Indian Leaders in 2018. She also won Khaleej Times’ Emerging Leaders Award 2018 for Healthcare. She is a Chartered Accountant from the ICAS (Institute of Chartered Accountants of Scotland) and worked earlier with Ernst & Young.
She graduated from the University of Michigan, Ann Arbor with distinction in Finance & Accounting.
Alisha’s philosophy in life is ‘Healthiness is Happiness’. She wants to enable quality healthcare across the globe through treating people with compassion, precision and excellence. She is dedicated to the cause of women empowerment and mental health. She believes in the diversity of workforce, strength in differences and focused on improving the glass ceilings at work for women. She was instrumental in launching the Women in Leadership program at Aster DM Healthcare which empowers talented and capable female employees with training and growth opportunities, to shape them for leadership roles.
She is also an active philanthropist, being a trustee of Aster DM Foundation and involved in social welfare through Aster Volunteers program which bridges the gap between people who would like to help with those in need.
Alisha Moopen is dedicated to ensuring that humanity leverages on advances in science as well as personal re-engineering of self, ranging from lifestyle choices to dealing with the external environment, to staying happy and healthy, both physically and mentally. She believes using technology can enable better health outcomes for population management through precision medicine, connected care and AI.
Social Media Links:
LinkedIn: Aster DM Healthcare
How to boost your immune system through your diet and balance the good bacteria in your gut
Dr. Glen N. Robison, who is a leading podiatrist and surgeon from Arizona as well as a bestselling author, Jin Shin Jyutsu practitioner, and certified myopractor joins eHealth Radio and the Health News Channel.
Listen to interview with host Eric Michaels and guest Dr. Glen N. Robison discuss the following:
In your book you argue that your immune system is precious. What are some things people can do to naturally guard or boost their immunity?
There are certain foods that have been labeled "immune boosters." What are some of those foods?
What role does the bacteria in our digestive system play in our immune systems?
What are some symptoms people experience when the bacteria in their digestive system is unbalanced?
Can you tell us how detoxing aids your digestive system?
Dr. Glen N. Robison Diplomate of the American Board of Multiple Specialties in Podiatry Board Certified in Primary Care in Podiatric Medicine. Dr. Robison is a Jin Shin Jyutsu practitioner and certified Myopractor, trained in releasing deep restrictions of motion in the body that resides at the root of our symptoms and ailments.
Having applied the principles found in this book for over fifteen years, he has expanded his practice to include dietary approaches that address everything from fungal infections to diabetes. Learn more at www.liveitlifestyles.com.
Social Media Links:
Healthy Dad Sick Dad Website
Céline Fournier, PhD, Chief Medical Officer, Echosens Discusses the Clinical Evidence and Future of Liver Screening Technology
Céline Fournier, PhD, the Chief Medical Officer of Echosens, a high-technology company offering the FibroScan family of products, joins eHealth Radio and the Health News and Technology Channels to discuss the robust clinical data FibroScan has and Echosens plan to continue building clinical evidence.
Listen to interview with host Eric Michaels and guest Dr. Céline Fournier discuss the following:
Could you tell us about the robust level of evidence FibroScan has and how many communications and guidelines recommend the value of FibroScan?
What is Echosens plan to continue building clinical evidence?
How might existing research on FibroScan impact NAFLD/NASH drug development?
If you were to look into the future when the drugs for fibrotic NASH become available, how do you see FibroScan best supporting clinical practice for managing patients on treatment?
Could you tell us about the clinical data strategy Echosens has in place and what long term goals you anticipate?
Céline Fournier, PhD, age 45, is presently Chief Medical Officer of Echosens (Paris, France). She graduated from University of Technology of Compiègne Engineering School (France) in Bioengineering in 1998. During the course of her engineering training, she studied one year at the University of Pennsylvania (Philadelphia, USA). She then went to the Laboratory of Parametric Imaging (Paris, France) to work on skin tissue characterization by ultrasound and defended her PhD in Bioengineering in 2002. She joined Echosens a few months later as Medical Affairs Manager to conduct the first multicenter clinical trial to validate the diagnosis performances of FibroScan. In 2012, she became Medical and Regulatory Affairs Director. As CMO since 2017, she is globally responsible for Clinical Operation, Medical Affairs as well as Clinical Application and Training.
Echosens, the developer of FibroScan®, is an innovative high-technology company offering a full range of products and services supporting physicians in their assessment and management of patients with chronic liver diseases. FibroScan is supported by over 2,500 peer-reviewed publications and examinations are covered by Medicare, Medicaid and many insurance plans.
Social Media Links:
JScreen.org: Saving Lives One Swab at a Time
Melanie Hardy, the Director of Genetic Counseling Services for the JScreen program joins eHealth Radio and the Health News Channel.
JScreen is a not-for-profit home education and carrier screening based out of Emory University that offers affordable at-home testing for individuals and families of Jewish descent who want to empower themselves with science-based knowledge to discover if they or their future children are at risk for Jewish genetic diseases such as Tay-Sachs, Cystic Fibrosis, or if they are at a higher risk of cancer. Unlike other screening programs, Jscreen, allows you to screen from the comfort of your own home.
Listen to interview with host Eric Michaels and guest Melanie Hardy discuss the following:
What is JScreen exactly? How did the service come to be called JScreen?
How did it start – tell us about the couple that came to you in Atlanta and their story about their child and the inspiration behind JsScreen?
How does it work for people who want to get Screened?
Who helps you understand the results – is there a doctor or Genetic Counselor who talks to you about the screening?
How long from when you order the tests until you receive results?
How many tests can you get at one time and what are costs?
I understand you just launched the CAncerGen service – tell us about this?
Talk to us more about ReproGen, is that all or is there other types of screenings?
Melanie Hardy is the Director of Genetic Counseling Services for the JScreen program. She graduated with a Bachelor’s degree in Biology from Michigan State University in 1998 and followed with a 9-year career as a high school biology, chemistry and forensics teacher. She received a Master’s degree in Biology from Georgia Southern University in 2009 and a Master’s degree in Genetic Counseling from the University of North Carolina at Greensboro in 2011. She was certified by the American Board of Genetic Counseling in 2012.
Before joining the JScreen team, Melanie worked as a prenatal genetic counselor in a Maternal Fetal Medicine specialty clinic in Richmond, VA. Her professional interests include community outreach and education, mentorship, provision of telehealth, and enhancement of the healthcare experience. In 2014, she was awarded the New Leader Award, and in 2019, she was awarded the Outstanding Volunteer Leadership Award, both by the National Society of Genetic Counselors, for involvement in a wide array of professional activities.
Social Media Links:
Discover Labs Provides Fast Diagnostic Testing for Patients Nationwide with Ernesto Lizardi
Ernesto Lizardi, the Vice President of Clinical Laboratories Operations & Senior R&D Molecular Scientist for Discover Labs located in Austin, TX joins eHealth Radio and the Health News Channel.
Listen to interview with host Eric Michaels and guest Ernesto Lizardi discuss the following:
Tell us about Discover Labs and how the company started.
What services does Discover Labs offer?
How long does it take to get test results?
I heard you and the team at Discover provided instrumental testing services to many organizations during the course of the pandemic. Could you give me some highlights?
Where can clinicians, doctors and nursing homes get more information?
Ernesto Lizardi was born and raised in Caguas, Puerto Rico. He graduated from Wayland Baptist University with his bachelor’s in molecular biology with a minor in Chemistry while playing baseball throughout the course of his bachelor's as a First Team All American Catcher and third in the nation in batting average. Later he attended Texas Tech University Health and Science Center and graduated with an Applied Master of Sciences in Molecular Pathology.
After receiving his education, Ernesto Lizardi started working as a Molecular Validation Specialist developing, validating, and implementing new Laboratory Developed Tests for different laboratories to expand their test menus while reducing their cost per test. In January 2020, Ernesto started researching SARS-CoV-2 (COVID-19) as a possibility for a new test to be implemented in the labs and since then Ernesto has developed, validated, and implemented over eight different SARS-CoV-2 (COVID-19) Assays while also being part of two different Emergency Use Authorization (EUA) submissions.
Now Ernesto Lizardi works at Discover labs helping with the day-to-day clinical testing, new test development, and compliance with CLIA/CAP regulations. Ernesto is currently working on a Laboratory Developed Test for a Respiratory Pathogen Panel with over 33 different targets that will be implemented before the next respiratory season to provide the tools necessary for the physicians to make an accurate diagnosis.
Love the podcast. Keep them coming!